Dashboard
Manage Tickers

ZVSAZyVersa Therapeutics, Inc.

Nasdaq lsprhealth.com


$ 5.56 $ -0.87 (-13.45 %)    

Wednesday, 08-May-2024 15:59:14 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 5.6
$ 6.16
$ 0.00 x 0
$ 0.00 x 0
$ 5.52 - $ 6.18
$ 4.44 - $ 213.50
137,940
na
546,020
$ 0.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-21-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 04-14-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

whats-going-on-with-zyversa-stock
What's Going On With ZyVersa Stock?
04/29/2024 14:53:43

ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a pe...

zyversa-therapeutics-shares-resume-trade-following-circuit-breaker-halt
ZyVersa Therapeutics Shares Resume Trade F...
04/29/2024 14:07:37

zyversa-therapeutics-announces-publication-reinforcing-the-rationale-for-inhibiting-asc-with-ic-100-to-potentially-attenuate-cardiac-comorbidities-in-patients-with-alzheimers-disease
ZyVersa Therapeutics Announces Publication...
04/29/2024 11:58:10

 ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA, or ", ZyVersa", )))), a clinical stage specialty biopharmaceutical company de...

why-aon-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Aon Shares Are Trading Lower By Around...
04/26/2024 17:56:57

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
04/26/2024 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
04/25/2024 23:50:04

zyversa-therapeutics-highlights-published-data-demonstrating-nlrp3-inflammasome-inhibition-has-potential-to-decrease-atherosclerotic-lesions-in-patients-with-diabetes
ZyVersa Therapeutics Highlights Published ...
04/04/2024 12:02:43

Atherosclerosis (AS) and its sequelae are the most common cause of death in diabetic patients and one of the reasons why diabet...

hc-wainwright--co-reiterates-buy-on-zyversa-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on ZyVe...
03/26/2024 10:16:56

HC Wainwright & Co. analyst Ed Arce reiterates ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy and maintains $12 price tar...

zyversa-therapeutics-fy23-eps-10897
ZyVersa Therapeutics FY23 EPS $(108.97)
03/25/2024 12:26:46

zyversa-therapeutics-announces-irb-approval-of-phase-2a-clinical-trial-protocol-to-evaluate-cholesterol-efflux-mediator-var-200-in-patients-with-diabetic-kidney-disease
ZyVersa Therapeutics Announces IRB Approva...
03/18/2024 11:58:07

 ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA, or ", ZyVersa", )))), a clinical stage specialty biopharmaceutical company de...

hc-wainwright--co-maintains-buy-on-zyversa-therapeutics-lowers-price-target-to-12
HC Wainwright & Co. Maintains Buy on ZyVer...
03/12/2024 12:24:34

HC Wainwright & Co. analyst Ed Arce maintains ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy and lowers the price target ...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 17:31:22

hc-wainwright--co-reiterates-buy-on-zyversa-therapeutics-maintains-24-price-target
HC Wainwright & Co. Reiterates Buy on ZyVe...
02/29/2024 14:09:22

HC Wainwright & Co. analyst Ed Arce reiterates ZyVersa Therapeutics (NASDAQ:ZVSA) with a Buy and maintains $24 price tar...

zyversa-therapeutics-highlights-data-from-review-article-published-in-nature-reinforcing-ic-100s-rationale-for-inhibiting-asc-and-asc-specks-to-attenuate-damaging-inflammation-associated-with-various-conditions-including-obesity-and-its-complications
ZyVersa Therapeutics Highlights Data From ...
02/28/2024 13:00:01

Obesity, which affects over 1.9 billion people worldwide, is a state of low-grade chronic inflammation that causes an array of ...

why-transmedics-group-shares-are-trading-higher-by-around-23-here-are-20-stocks-moving-premarket
Why TransMedics Group Shares Are Trading H...
02/27/2024 12:56:22

Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-...

why-freshpet-shares-are-trading-higher-by-around-15-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Freshpet Shares Are Trading Higher By ...
02/26/2024 18:57:55

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
02/26/2024 17:31:06

what-in-the-world-is-going-on-with-zyversa-therapeutics-zvsa-stock
What In The World Is Going On With ZyVersa...
02/26/2024 15:04:51

ZyVersa Therapeutics shares are trading higher by 126% Monday. The stock continues to be volatile after the company last week r...

zyversa-therapeutics-shares-resumed-trade
ZyVersa Therapeutics Shares Resumed Trade
02/26/2024 14:51:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION